Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2023-01-24T18:01:40+01:0019/01/2023| Lire la suite
Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes? Jessica LAUBERT2022-12-28T10:48:48+01:0022/10/2022| Lire la suite
Do diabetic patients receiving an innovative treatment have a lower risk of being hospitalized? Evidence from French insurance claims data Jessica LAUBERT2018-07-16T16:59:58+01:0011/07/2018| Lire la suite
Do diabetic patients receiving an innovative treatment have a lower risk of being hospitalized? Evidence from French insurance claims data Jessica LAUBERT2018-06-29T14:46:40+01:0014/05/2018| Lire la suite
Médicament innovant du diabète et risque d’hospitalisation Jessica LAUBERT2018-07-16T17:08:10+01:0013/03/2018| Lire la suite
